 "Dr Reddys Lab gains on share buyback plan")
Dr Reddys Laboratories has moved higher by 3% to Rs 2,978 on the National Stock Exchange (NSE) in an early morning trade after the drug maker announced share buyback plan.
“A meeting of the board of directors of the company will be held on February 17, 2016, to consider the buyback of equity shares of the company,” Dr Reddys Laboratories said in a statement.
As of December 31, 2015, the promoters held 25.57% stake in Dr Reddy’s Laboratories, while the public shareholders held 74.43% holding, the shareholding pattern data shows.
In past six months, the stock has underperformed the market by falling 32% as compared to 15% decline in Nifty50 index till yesterday.
At 09:30 AM, the stock was up 2.5% at Rs 2,958 against 0.44% fall in the benchmark index. A combined 153,303 shares changed hands on the counter on the NSE and BSE.
“A meeting of the board of directors of the company will be held on February 17, 2016, to consider the buyback of equity shares of the company,” Dr Reddys Laboratories said in a statement.
As of December 31, 2015, the promoters held 25.57% stake in Dr Reddy’s Laboratories, while the public shareholders held 74.43% holding, the shareholding pattern data shows.
In past six months, the stock has underperformed the market by falling 32% as compared to 15% decline in Nifty50 index till yesterday.
At 09:30 AM, the stock was up 2.5% at Rs 2,958 against 0.44% fall in the benchmark index. A combined 153,303 shares changed hands on the counter on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%